Japanese trading and investment company Sumitomo Corporation, jointly with Kazatomprom, is developing a project in nuclear medicine, aiming to extract medical isotopes from uranium, the Akorda press service reported.
President Kassym-Jomart Tokayev met with Shingo Ueno, president and CEO of Sumitomo Corporation, who reported on the joint project with Kazatomprom.
The companies are looking to extract medical radioisotopes from uranium production by-products. Tokayev acknowledged Sumitomo’s commitment to sustainable growth and responsible business practices.
During the meeting, the parties also discussed cooperation prospects, as well as the development of joint projects in transport, logistics, energy, the nuclear...